Which has preferable earnings & valuation, EUDAW or ASPSW?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio EUDA Health $6.82M N/A N/A N/A N/A Altisource Portfolio Solutions $182.50M N/A N/A N/A N/A

Is EUDAW or ASPSW more profitable?

Company Net Margins Return on Equity Return on Assets EUDA Health N/A N/A N/A Altisource Portfolio Solutions N/A N/A N/A

Do analysts recommend EUDAW or CBRE?

CBRE Group has a consensus target price of $180.33, indicating a potential upside of 19.33%. Given CBRE Group's stronger consensus rating and higher possible upside, analysts clearly believe CBRE Group is more favorable than EUDA Health. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score EUDA Health 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 CBRE Group 0 Sell rating(s) 1 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.88

Which has higher valuation & earnings, EUDAW or CBRE?

CBRE Group has higher revenue and earnings than EUDA Health. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio EUDA Health $6.82M N/A N/A N/A N/A CBRE Group $40.55B 1.08 $1.16B $4.36 34.66

Does the media prefer EUDAW or CBRE?

In the previous week, CBRE Group had 1 more articles in the media than EUDA Health. MarketBeat recorded 3 mentions for CBRE Group and 2 mentions for EUDA Health. EUDA Health's average media sentiment score of 0.93 beat CBRE Group's score of 0.88 indicating that EUDA Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment EUDA Health 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive CBRE Group 3 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts prefer BEKE or EUDAW?

KE presently has a consensus price target of $23.64, suggesting a potential upside of 29.18%. Given KE's stronger consensus rating and higher possible upside, analysts plainly believe KE is more favorable than EUDA Health. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score KE 0 Sell rating(s) 1 Hold rating(s) 6 Buy rating(s) 1 Strong Buy rating(s) 3.00 EUDA Health 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has higher valuation & earnings, BEKE or EUDAW?

KE has higher revenue and earnings than EUDA Health. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio KE $13.52B 1.51 $428.13M $0.61 30.00 EUDA Health $6.82M N/A N/A N/A N/A

Is BEKE or EUDAW more profitable?

KE has a net margin of 5.38% compared to EUDA Health's net margin of 0.00%. KE's return on equity of 7.62% beat EUDA Health's return on equity. Company Net Margins Return on Equity Return on Assets KE 5.38% 7.62% 4.38% EUDA Health N/A N/A N/A

Does the media favor BEKE or EUDAW?

In the previous week, KE had 7 more articles in the media than EUDA Health. MarketBeat recorded 9 mentions for KE and 2 mentions for EUDA Health. KE's average media sentiment score of 0.94 beat EUDA Health's score of 0.93 indicating that KE is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment KE 3 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive EUDA Health 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts rate JLL or EUDAW?

Jones Lang LaSalle currently has a consensus price target of $433.60, suggesting a potential upside of 14.42%. Given Jones Lang LaSalle's stronger consensus rating and higher probable upside, analysts plainly believe Jones Lang LaSalle is more favorable than EUDA Health. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Jones Lang LaSalle 0 Sell rating(s) 2 Hold rating(s) 4 Buy rating(s) 1 Strong Buy rating(s) 2.86 EUDA Health 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has higher earnings & valuation, JLL or EUDAW?

Jones Lang LaSalle has higher revenue and earnings than EUDA Health. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Jones Lang LaSalle $26.12B 0.67 $792.10M $20.87 18.16 EUDA Health $6.82M N/A N/A N/A N/A

Does the media prefer JLL or EUDAW?

In the previous week, Jones Lang LaSalle had 29 more articles in the media than EUDA Health. MarketBeat recorded 31 mentions for Jones Lang LaSalle and 2 mentions for EUDA Health. Jones Lang LaSalle's average media sentiment score of 1.11 beat EUDA Health's score of 0.93 indicating that Jones Lang LaSalle is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Jones Lang LaSalle 15 Very Positive mention(s) 0 Positive mention(s) 8 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive EUDA Health 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts prefer EUDAW or CSGP?

CoStar Group has a consensus target price of $40.11, suggesting a potential upside of 24.47%. Given CoStar Group's stronger consensus rating and higher probable upside, analysts plainly believe CoStar Group is more favorable than EUDA Health. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score EUDA Health 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 CoStar Group 2 Sell rating(s) 9 Hold rating(s) 9 Buy rating(s) 0 Strong Buy rating(s) 2.35

Which has higher valuation and earnings, EUDAW or CSGP?

CoStar Group has higher revenue and earnings than EUDA Health. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio EUDA Health $6.82M N/A N/A N/A N/A CoStar Group $3.25B 4.02 $7M $0.19 169.58

Does the media prefer EUDAW or CSGP?

In the previous week, CoStar Group had 23 more articles in the media than EUDA Health. MarketBeat recorded 25 mentions for CoStar Group and 2 mentions for EUDA Health. CoStar Group's average media sentiment score of 1.37 beat EUDA Health's score of 0.93 indicating that CoStar Group is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment EUDA Health 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive CoStar Group 20 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

EUDA Health (EUDAW) Competitors

$0.03 0.00 (-6.38%)

As of 08/28/2026 03:48 PM Eastern

Compare

EUDAW vs. ASPSW, CBRE, BEKE, JLL, and CSGP

Should you buy EUDA Health stock or one of its competitors? EUDA Health's main competitors and comparable companies include Altisource Portfolio Solutions (ASPSW), CBRE Group (CBRE), KE (BEKE), Jones Lang LaSalle (JLL), and CoStar Group (CSGP). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "real estate services" industry.

How does EUDA Health compare to Altisource Portfolio Solutions?

EUDA Health (NASDAQ:EUDAW) and Altisource Portfolio Solutions (NASDAQ:ASPSW) are both real estate companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, institutional ownership, media sentiment, valuation, dividends, risk and profitability.

In the previous week, EUDA Health had 1 more articles in the media than Altisource Portfolio Solutions. MarketBeat recorded 2 mentions for EUDA Health and 1 mentions for Altisource Portfolio Solutions. Altisource Portfolio Solutions' average media sentiment score of 1.90 beat EUDA Health's score of 0.93 indicating that Altisource Portfolio Solutions is being referred to more favorably in the news media.

Company	Overall Sentiment
EUDA Health	Positive
Altisource Portfolio Solutions	Very Positive

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
EUDA Health	$6.82M	N/A	N/A	N/A	N/A
Altisource Portfolio Solutions	$182.50M	N/A	N/A	N/A	N/A

Company	Net Margins	Return on Equity	Return on Assets
EUDA Health	N/A	N/A	N/A
Altisource Portfolio Solutions	N/A	N/A	N/A

Summary

Altisource Portfolio Solutions beats EUDA Health on 2 of the 3 factors compared between the two stocks.

How does EUDA Health compare to CBRE Group?

EUDA Health (NASDAQ:EUDAW) and CBRE Group (NYSE:CBRE) are both real estate companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, risk, earnings, analyst recommendations, valuation, dividends, media sentiment and institutional ownership.

CBRE Group has a net margin of 2.98% compared to EUDA Health's net margin of 0.00%. CBRE Group's return on equity of 25.12% beat EUDA Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
EUDA Health	N/A	N/A	N/A
CBRE Group	2.98%	25.12%	7.46%

CBRE Group has a consensus target price of $180.33, indicating a potential upside of 19.33%. Given CBRE Group's stronger consensus rating and higher possible upside, analysts clearly believe CBRE Group is more favorable than EUDA Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
EUDA Health	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
CBRE Group	0 Sell rating(s)	1 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.88

In the previous week, CBRE Group had 1 more articles in the media than EUDA Health. MarketBeat recorded 3 mentions for CBRE Group and 2 mentions for EUDA Health. EUDA Health's average media sentiment score of 0.93 beat CBRE Group's score of 0.88 indicating that EUDA Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
EUDA Health	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
CBRE Group	3 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

98.4% of CBRE Group shares are held by institutional investors. 0.5% of CBRE Group shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

CBRE Group has higher revenue and earnings than EUDA Health.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
EUDA Health	$6.82M	N/A	N/A	N/A	N/A
CBRE Group	$40.55B	1.08	$1.16B	$4.36	34.66

Summary

CBRE Group beats EUDA Health on 10 of the 11 factors compared between the two stocks.

How does EUDA Health compare to KE?

KE (NYSE:BEKE) and EUDA Health (NASDAQ:EUDAW) are both real estate companies, but which is the better stock? We will contrast the two companies based on the strength of their earnings, institutional ownership, valuation, risk, dividends, profitability, media sentiment and analyst recommendations.

In the previous week, KE had 7 more articles in the media than EUDA Health. MarketBeat recorded 9 mentions for KE and 2 mentions for EUDA Health. KE's average media sentiment score of 0.94 beat EUDA Health's score of 0.93 indicating that KE is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
KE	3 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
EUDA Health	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

KE presently has a consensus price target of $23.64, suggesting a potential upside of 29.18%. Given KE's stronger consensus rating and higher possible upside, analysts plainly believe KE is more favorable than EUDA Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
KE	0 Sell rating(s)	1 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	3.00
EUDA Health	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

KE has a net margin of 5.38% compared to EUDA Health's net margin of 0.00%. KE's return on equity of 7.62% beat EUDA Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
KE	5.38%	7.62%	4.38%
EUDA Health	N/A	N/A	N/A

39.3% of KE shares are owned by institutional investors. 6.8% of KE shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

KE has higher revenue and earnings than EUDA Health.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
KE	$13.52B	1.51	$428.13M	$0.61	30.00
EUDA Health	$6.82M	N/A	N/A	N/A	N/A

Summary

KE beats EUDA Health on 12 of the 12 factors compared between the two stocks.

How does EUDA Health compare to Jones Lang LaSalle?

Jones Lang LaSalle (NYSE:JLL) and EUDA Health (NASDAQ:EUDAW) are both real estate companies, but which is the superior investment? We will contrast the two businesses based on the strength of their profitability, media sentiment, risk, institutional ownership, valuation, dividends, earnings and analyst recommendations.

In the previous week, Jones Lang LaSalle had 29 more articles in the media than EUDA Health. MarketBeat recorded 31 mentions for Jones Lang LaSalle and 2 mentions for EUDA Health. Jones Lang LaSalle's average media sentiment score of 1.11 beat EUDA Health's score of 0.93 indicating that Jones Lang LaSalle is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Jones Lang LaSalle	15 Very Positive mention(s)	0 Positive mention(s)	8 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
EUDA Health	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Jones Lang LaSalle has higher revenue and earnings than EUDA Health.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Jones Lang LaSalle	$26.12B	0.67	$792.10M	$20.87	18.16
EUDA Health	$6.82M	N/A	N/A	N/A	N/A

Jones Lang LaSalle currently has a consensus price target of $433.60, suggesting a potential upside of 14.42%. Given Jones Lang LaSalle's stronger consensus rating and higher probable upside, analysts plainly believe Jones Lang LaSalle is more favorable than EUDA Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Jones Lang LaSalle	0 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.86
EUDA Health	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

94.8% of Jones Lang LaSalle shares are held by institutional investors. 0.9% of Jones Lang LaSalle shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Jones Lang LaSalle has a net margin of 3.64% compared to EUDA Health's net margin of 0.00%. Jones Lang LaSalle's return on equity of 13.99% beat EUDA Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Jones Lang LaSalle	3.64%	13.99%	5.96%
EUDA Health	N/A	N/A	N/A

Summary

Jones Lang LaSalle beats EUDA Health on 12 of the 12 factors compared between the two stocks.

How does EUDA Health compare to CoStar Group?

EUDA Health (NASDAQ:EUDAW) and CoStar Group (NASDAQ:CSGP) are both real estate companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, media sentiment, profitability, valuation, institutional ownership, dividends, risk and analyst recommendations.

CoStar Group has a consensus target price of $40.11, suggesting a potential upside of 24.47%. Given CoStar Group's stronger consensus rating and higher probable upside, analysts plainly believe CoStar Group is more favorable than EUDA Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
EUDA Health	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
CoStar Group	2 Sell rating(s)	9 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.35

In the previous week, CoStar Group had 23 more articles in the media than EUDA Health. MarketBeat recorded 25 mentions for CoStar Group and 2 mentions for EUDA Health. CoStar Group's average media sentiment score of 1.37 beat EUDA Health's score of 0.93 indicating that CoStar Group is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
EUDA Health	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
CoStar Group	20 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

CoStar Group has higher revenue and earnings than EUDA Health.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
EUDA Health	$6.82M	N/A	N/A	N/A	N/A
CoStar Group	$3.25B	4.02	$7M	$0.19	169.58

96.6% of CoStar Group shares are held by institutional investors. 1.2% of CoStar Group shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

CoStar Group has a net margin of 2.08% compared to EUDA Health's net margin of 0.00%. CoStar Group's return on equity of 3.74% beat EUDA Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
EUDA Health	N/A	N/A	N/A
CoStar Group	2.08%	3.74%	2.96%

Summary

CoStar Group beats EUDA Health on 11 of the 11 factors compared between the two stocks.

Get EUDA Health News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding EUDAW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

EUDAW vs. The Competition

Export

Metric	EUDA Health	Real Estate Management & Development Industry	Real Estate Sector	NASDAQ Exchange
Market Cap	N/A	$3.33B	$5.65B	$12.93B
Dividend Yield	N/A	4.32%	6.32%	10.96%
P/E Ratio	N/A	14.53	28.78	25.38
Price / Sales	N/A	91.63	128.10	96.54
Price / Cash	N/A	20.17	34.53	54.21
Price / Book	N/A	2.10	1.88	6.14
Net Income	N/A	-$438.94M	-$64.48M	$347.93M
7 Day Performance	N/A	-0.26%	-0.40%	-0.78%
1 Month Performance	N/A	0.72%	-1.12%	5.60%
1 Year Performance	N/A	-8.41%	11.23%	15.64%

EUDA Health Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
EUDAW EUDA Health	N/A	$0.03 -6.4%	N/A	-78.1%	$0.00	$6.82M	N/A	150	Upcoming Earnings Gap Up
ASPSW Altisource Portfolio Solutions	N/A	$0.35 +12.1%	N/A	N/A	$0.00	$182.50M	N/A	N/A	Gap Down
CBRE CBRE Group	4.2678 of 5 stars	$154.99 +5.2%	$181.00 +16.8%	-6.7%	$42.65B	$40.55B	35.55	155,000
BEKE KE	4.7197 of 5 stars	$17.36 +2.9%	$23.37 +34.6%	+4.6%	$18.88B	$13.52B	41.33	119,245	News Coverage Earnings Report Analyst Upgrade Gap Up
JLL Jones Lang LaSalle	4.7535 of 5 stars	$389.86 +5.1%	$423.33 +8.6%	+24.4%	$17.07B	$26.12B	18.68	113,200	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:EUDAW) was last updated on 8/29/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

EUDA Health (EUDAW) Competitors

EUDAW vs. ASPSW, CBRE, BEKE, JLL, and CSGP

How does EUDA Health compare to Altisource Portfolio Solutions?

Summary

How does EUDA Health compare to CBRE Group?

Summary

How does EUDA Health compare to KE?

Summary

How does EUDA Health compare to Jones Lang LaSalle?

Summary

How does EUDA Health compare to CoStar Group?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

EUDAW vs. The Competition

EUDA Health Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

EUDA Health (EUDAW) Competitors

EUDAW vs. ASPSW, CBRE, BEKE, JLL, and CSGP

How does EUDA Health compare to Altisource Portfolio Solutions?

Does the media refer more to EUDAW or ASPSW?

Which has preferable earnings & valuation, EUDAW or ASPSW?

Is EUDAW or ASPSW more profitable?

Summary

How does EUDA Health compare to CBRE Group?

Is EUDAW or CBRE more profitable?

Do analysts recommend EUDAW or CBRE?

Does the media prefer EUDAW or CBRE?

Do institutionals & insiders hold more shares of EUDAW or CBRE?

Which has higher valuation & earnings, EUDAW or CBRE?

Summary

How does EUDA Health compare to KE?

Does the media favor BEKE or EUDAW?

Do analysts prefer BEKE or EUDAW?

Is BEKE or EUDAW more profitable?

Do institutionals and insiders have more ownership in BEKE or EUDAW?

Which has higher valuation & earnings, BEKE or EUDAW?

Summary

How does EUDA Health compare to Jones Lang LaSalle?

Does the media prefer JLL or EUDAW?

Which has higher earnings & valuation, JLL or EUDAW?

Do analysts rate JLL or EUDAW?

Do insiders and institutionals have more ownership in JLL or EUDAW?

Is JLL or EUDAW more profitable?

Summary

How does EUDA Health compare to CoStar Group?

Do analysts prefer EUDAW or CSGP?

Does the media prefer EUDAW or CSGP?

Which has higher valuation and earnings, EUDAW or CSGP?

Do insiders & institutionals have more ownership in EUDAW or CSGP?

Is EUDAW or CSGP more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

EUDAW vs. The Competition

EUDA Health Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools